Palliative care for AML patients on venetoclax-based therapy: A single-center real-world study

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Early and sustained palliative care intervention is not superior to on-demand palliative care referral for patients with high-risk leukemias or myelodysplastic syndrome2025
2. 2Palliative care consultation reduces hospital costs and length of stay among decedents with hematologic malignancies: A propensity score matched analysis from the national inpatient sample, 2016-20222025
3. 3Outcomes of low-intensity AML therapy based on treatment facility2025
4. 4Intensive chemotherapy versus venetoclax–hypomethylating agents therapy for acute myeloid leukemia: A large real-world propensity-matched study.2026
5. 5Characterizing palliative care utilization among patients with Acute Myeloid Leukemia (AML): Insights from analysis of AML hospitalizations in the United States.2025